Evidence map›Paper›PMID 36354468›Full record

ArticleBiosensors2022

Ultrasensitive Detection of C-Reactive Protein by a Novel Nanoplasmonic Immunoturbidimetry Assay.

Tang Dang, Zhenyu Li, Liyuan Zhao, Wei Zhang, Liping Huang, Fanling Meng, Gang Logan Liu, Wenjun Hu

Open access · goldAbstract read
In one paragraph

Article in Biosensors, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.0field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 14 citations in OpenAlex.

  1. High-performance photothermal GA-MoSeJournal of nanobiotechnology · 2026
    Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Tang DangSchool of Life Science and Technology, Huazhong University of Science and Technology, Wuhan 430022, China.
Zhenyu LiCancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1277 JieFang Avenue, Wuhan 430022, China.
Liyuan ZhaoNational Engineering Research Center for Nanomedicine, College of Life Science and Technology, Huazhong University of Science and Technology, Wuhan 430074, China.
Wei ZhangSchool of Life Science and Technology, Huazhong University of Science and Technology, Wuhan 430022, China.
Liping HuangSchool of Life Science and Technology, Huazhong University of Science and Technology, Wuhan 430022, China.
Fanling MengNational Engineering Research Center for Nanomedicine, College of Life Science and Technology, Huazhong University of Science and Technology, Wuhan 430074, China.
Gang Logan LiuSchool of Life Science and Technology, Huazhong University of Science and Technology, Wuhan 430022, China.
Wenjun HuSchool of Life Science and Technology, Huazhong University of Science and Technology, Wuhan 430022, China.ORCID 0000-0001-8563-8844
Huazhong University of Science and Technology · CNUnion Hospital · CN

Funding

Fundamental Research Funds for the Central Universities 2019kfyXMPY002Major Research Program of National Nat-ural Science Foundation of China 91959107National Key R&D Program of China 2020YFC0861900National Nature Science Foundation of China 82072735
6 · The paper itself

Abstract

Nanotechnology has attracted much attention, and may become the key to a whole new world in the fields of food, agriculture, building materials, machinery, medicine, and electrical engineering, because of its unique physical and chemical properties, including high surface area and outstanding electrical and optical properties. The bottom-up approach in nanofabrication involves the growth of particles, and we were inspired to propose a novel nanoplasmonic method to detect the formation of nanoparticles in real time. This innovative idea may contribute to the promotion of nanotechnology development. An increase in nanometer particle size leads to optical extinction or density (OD)-value changes in our nanosensor chip at a specific wavelength measured in a generic microplate reader. Moreover, in applying this method, an ultrasensitive nanoplasmonic immunoturbidimetry assay (NanoPITA) was carried out for the high-throughput quantification of hypersensitive C-reactive protein (CRP), a well-known biomarker of cardiovascular, inflammatory, and tumor diseases. The one-step detection of the CRP concentration was completed in 10 min with high fidelity, using the endpoint analysis method. The new NanoPITA method not only produced a linear range from 1 ng/mL to 500 ng/mL CRP with the detection limit reduced to 0.54 ng/mL, which was an improvement of over 1000 times, with respect to regular immunoturbidity measurement, but was also effective in blood detection. This attractive method, combined with surface plasmon resonance and immunoturbidimetry, may become a new technology platform in the application of biological detection.

Indexed as

Biosensing TechniquesC-Reactive ProteinBiomarkersImmunoturbidimetryNanotechnologySurface Plasmon ResonanceBiomarkersC-Reactive ProteinC-reactive proteinnanophotonicsone-step detectionrapid diagnosticssurface plasmon resonanceultrasensitive detection

Identifiers

PMID36354468
PMCPMC9688280
OpenAlexW4308332305

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.